Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The LUC7-like family comprises three human proteins (LUC7L, LUC7L2, LUC7L3) that are conserved nuclear zinc finger-containing splicing factors. They are fundamental components of the spliceosome and function primarily to regulate pre-mRNA splicing by interacting with small nuclear RNAs (notably U1 snRNA) and specifying 5' splice-site selection. Each member has a somewhat distinct binding pattern on pre-mRNAs and tissue-specific expression, enabling fine-tuned regulation of constitutive and alternative splicing. LUC7-like proteins are essential for normal cell function, differentiation, and play a critical role in hematopoietic cells. Dysfunction or loss, especially of LUC7L2, is linked to impaired splicing and certain leukemias.
Modulation of pre-mRNA splicing, mainly by influencing recognition and usage of 5' splice sites when targeted by splicing regulatory molecules
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on LUC7-like pre-mRNA splicing factor family member (LUC7L (for LUC7-like protein 1), LUC7L2 (for LUC7-like protein 2), LUC7L3 (for LUC7-like protein 3)).